Skip to content

‘Big Short’ Michael Burry doubles down on 2 Chinese stocks

‘Big Short’ Michael Burry doubles down on 2 Chinese stocks

The 13-f filing covering the fourth quarter of 2023 proved exciting and insightful as it demonstrated that ‘The Big Short’ investor Michael Burry has given up on his bet against the semiconductor industry and instead entered more than a dozen new long positions.

The more recent filing, unveiled on May 15, proved equally interesting. 

On the one hand, it showed that Burry has significantly consolidated his portfolio by selling off the shares of numerous companies – many of them, such as the blue-chips Amazon (NASDAQ: AMZN) and Alphabet (NASDAQ: GOOGL), and wildcards like GEN Restaurant Group (NASDAQ: GENK), being massive winners of recent months.

On the other, the document reveals that ‘The Big Short’ investor has doubled down on some of his more controversial investments, increasing his position in the top two holdings to over $20 million.

Alibaba (NYSE: BABA)

Michael Burry’s bet on the Chinese e-commerce and technology giant Alibaba (NYSE: BABA) has been a much-discussed topic ever since he made the initial investment during the penultimate quarter of 2023.

A major reason for the interest has been that the famous investor bought the stock when it was close to its 12-month highs and has, in fact, mostly been in the red since – at least when it comes to the initial batch of 50,000 shares.

Despite this, Burry has been steadily growing the investment, and according to the latest filing, he now holds 125,000 shares worth just over $10 million.

The Big Short’ investor’s bet now appears poised to turn green in its entirety as BABA stock has, after staggering in the immediate wake of the latest earnings report, entered a strong rally. 

Alibaba stock price today stands at $87.89 – near the initial purchase price – and is up 17.56% year-to-date (YTD).

BABA stock YTD price chart. Source: Finbold

JD.Com Inc (NASDAQ: JD)

Though nowhere near as discussed as the Alibaba bet, Burry’s JD.Com (NASDAQ: JD) investment, by the end of Q1 2024, grew to become his biggest.

Much like BABA, Burry first bought JD shares – 125,000 of them – during the third quarter of 2023. Also, like Alibaba, China’s other major e-commerce company has seen its share price significantly lower in the stock market than during the trimester of purchase.

Despite this, ‘The Big Short’ investor has been steadily increasing his position and, according to the latest available information, now holds 360,000 shares worth more than $23 million.

JD stock 1-year price chart. Source: Google

Finally, again mimicking its compatriot, the Chinese firm has been on a uptrend in recent weeks and JD price today stands at $34.27 following a 25.99% rise since January 2. It is, however, not as close to regaining last summer’s highs as Alibaba stock is.

Buy stocks now with eToro – trusted and advanced investment platform

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in 70+ cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. eToro USA LLC does not offer CFDs, only real Crypto assets available. Don’t invest unless you’re prepared to lose all the money you invest.

Read Next:

Weekly Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.